Shares of Prime Medicine ( PRME 13.07%) are surging on Thursday. The gene-editing company's stock gained 10.5% as of 2 p.m.

News of a fresh investigational program was putting some zip into the shares of gene-editing company Prime Medicine (NASDAQ: ...

Shares of Prime Medicine, Inc. (NYSE:PRME – Get Free Report) have earned a consensus rating of “Buy” from the ten brokerages ...

Prime Medicine announced yesterday a new preclinical program for treating alpha-1 antitrypsin deficiency (AATD), a genetic disorder affecting lung and liver function. The announcement included ...

Explore UiPath stock price, quotes ... Wood-led funds made significant trades involving GitLab, Intellia, Prime Medicine, UiPath, Ibotta, Roblox, Repare Therapeutics, and CareDx.

Defensive stocks are surging as investors have been shifting their focus. Growth stocks dominated the past two years.

Australia said on Sunday that Donald Trump’s return to the White House is now threatening to wreck the global economy.

Learn more about whether Globus Medical, Inc. or Lantheus Holdings, Inc. is a better investment based on AAII's A+ Investor ...

Mallinckrodt PLC, an Irish pharmaceutical company with a big footprint and long history in the St. Louis area, will buy U.S.

Small towns are ideal for weekend getaways, offering just enough diversions to be entertaining without being overwhelming, ...